Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up

Go back to Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up
(NASDAQ: CLOV) Delayed: 4.44 -0.11 (2.42%)
Previous Close $4.55    52 Week High
Open $4.60    52 Week Low
Day High $4.60    P/E N/A 
Day Low $4.41    EPS
Volume 1,465,435